Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1101 | 1018 | 1120 | 1277 | 1333 | 1800 |
Fund Return | 10.1% | 1.82% | 11.98% | 8.49% | 5.92% | 6.05% |
Place in category | 200 | 327 | 389 | 88 | 138 | 91 |
% in Category | 46 | 67 | 85 | 20 | 35 | 35 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CF Canlife Global Equity Fund C Acc | 12.53M | 11.92 | 8.70 | 11.60 | ||
CF Canlife Portfolio V Fund C Acc | 149.59M | 7.02 | 3.63 | 5.94 | ||
CF Canlife North American Fund C Ac | 16.02M | 11.50 | 9.56 | 13.80 | ||
CF Canlife Portfolio III Fund C Acc | 39.99M | 3.65 | 0.11 | 3.27 | ||
CF Canlife Portfolio III Fund C Inc | 1.36M | 3.64 | 0.11 | 3.27 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GB00B2PLJH12 | 2.05B | 12.38 | 8.81 | 7.01 | ||
TB Evenlode Income B Income | 3.27B | 5.22 | 5.85 | 8.72 | ||
UK Equity Income Fund Institutional | 90.61M | -2.24 | 7.61 | 5.51 | ||
UK Equity Income Fund Retail Income | 137.7M | -2.33 | 7.02 | 4.93 | ||
UK Equity Income Fund Retail Accumu | 115.21M | 9.74 | 6.41 | 6.24 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 8.31 | 10,114.0 | -8.40% | |
Shell | GB00BP6MXD84 | 8.06 | 31.41 | +0.64% | |
Unilever | GB00B10RZP78 | 6.75 | 56.30 | -0.07% | |
HSBC | GB0005405286 | 3.85 | 722.40 | +0.65% | |
National Grid | GB00BDR05C01 | 3.75 | 991.40 | +0.83% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Neutral | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review